Ensemble Therapeutics

company

About

Ensemble Therapeutics is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biotechnology
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Close

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Ensemble Therapeutics has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on May 12, 2004 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2004 Series A $15M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ensemble Therapeutics is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series A